Mercy University Hospital is a general hospital located in Cork, Ireland. It is managed by South/Southwest Hospital Group.

There are 330 beds in Mercy University Hospital.

During the past decade, Mercy University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy University Hospital" #1 sponsor was "Cancer Trials Ireland" with 3 trials, followed by "Mercy University Hospital, Cork, Ireland" with 1 trials sponsored, "Royal College of Surgeons, Ireland" with 1 trials sponsored, "Tampere University" with 1 trials sponsored and "University College Cork" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy University Hospital" #1 collaborator was "Health Service Executive" with 1 trials as a collaborator, "St. James's Hospital, Ireland" with 1 trials as a collaborator and "The Adelaide and Meath Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Mercy University Hospital" are "Colorectal Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Breast Cancer" (1 trials), "Colorectal Disease" (1 trials) and "Frail Older Adults" (1 trials). Many other conditions were trialed in "Mercy University Hospital" in a lesser frequency.

Most popular intervention types in "Mercy University Hospital" are "Drug" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (2 trials), "Capecitabine" (1 trials), "Docetaxel" (1 trials), "EndoVe endoscopic electroporation" (1 trials) and "Epirubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy University Hospital" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mercy University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy University Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".